 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/17/2024 |
$2.25 |
$2.35 |
$2.05 |
$2.24 |
41.10K | | 04/18/2024 |
$2.28 |
$2.36 |
$2.14 |
$2.24 |
91.90K | | 04/19/2024 |
$2.18 |
$2.30 |
$2.18 |
$2.25 |
10.10K | | 04/22/2024 |
$2.33 |
$2.50 |
$2.28 |
$2.43 |
13.10K | | 04/23/2024 |
$2.41 |
$2.51 |
$2.36 |
$2.51 |
12.00K |
|
|
| CASI Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapeutics and pharmaceutical products in China, the U.S., and throughout the world.. In China, Co.'s first commercial product, EVOMELA® is approved for use as a conditioning treatment prior to stem cell transplantation and as a palliative treatment for patients with multiple myeloma. The other core hematology/oncology assets in our pipeline include: CNCT19, which is being developed as a potential treatment for patients with hematological malignancies which express CD19 including, B-cell acute lymphoblastic leukemia and B-cell non-Hodgkin lymphoma. | |
|
CASI Pharmaceuticals (CASI) has the following price history information. Looking back at CASI historical stock prices for the last five trading days, on April 17, 2024, CASI opened at $2.25, traded as high as $2.35 and as low as $2.05, and closed at $2.24. Trading volume was a total of 41.10K shares. On April 18, 2024, CASI opened at $2.28, traded as high as $2.36 and as low as $2.14, and closed at $2.24. Trading volume was a total of 91.90K shares. On April 19, 2024, CASI opened at $2.18, traded as high as $2.30 and as low as $2.18, and closed at $2.25. Trading volume was a total of 10.10K shares. On April 22, 2024, CASI opened at $2.33, traded as high as $2.50 and as low as $2.28, and closed at $2.43. Trading volume was a total of 13.10K shares. On April 23, 2024, CASI opened at $2.41, traded as high as $2.51 and as low as $2.36, and closed at $2.51. Trading volume was a total of 12.00K shares.
CASI Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into CASI Pharmaceuticals shares, starting with a $10,000 purchase of CASI, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/25/2014 |
|
| End date: |
04/23/2024 |
|
| Start price/share: |
$18.90 |
|
| End price/share: |
$2.51 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-86.72% |
|
| Average Annual Total Return: |
-18.28% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$1,327.53 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/17/2024 | $2.24 | | 04/18/2024 | $2.24 | | 04/19/2024 | $2.25 | | 04/22/2024 | $2.43 | | 04/23/2024 | $2.51 |
|
|
Free CASI Email Alerts:
